$100 Invested In Biomarin Pharmaceutical 20 Years Ago Would Be Worth This Much Today
Portfolio Pulse from Benzinga Insights
Biomarin Pharmaceutical (NASDAQ:BMRN) has significantly outperformed the market over the past 20 years, delivering an average annual return of 14.87%. A $100 investment in BMRN 20 years ago would be worth $1,718.66 today. The company's current market capitalization is $16.09 billion.
July 18, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Biomarin Pharmaceutical has delivered an impressive average annual return of 14.87% over the past 20 years, significantly outperforming the market. A $100 investment 20 years ago would now be worth $1,718.66.
The article highlights Biomarin Pharmaceutical's strong historical performance, which is likely to positively influence investor sentiment and potentially drive short-term stock price appreciation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100